摘要
为了探讨重症肌无力的发病机制利用逆转录-聚合酶链反应(RT-PCR)、狭缝印迹技术和非放射性地高辛配基(DIG)DNA标记和检测手段,采用分子生物学技术和免疫学反应相结合,定量检测了重症肌无力(MG)患者和健康对照外周血单个核细胞(PBMC)的白细胞介素-2信使核糖核酸(IL-2mRNA)表达水平。结果表明:RT-PCR方法特异而灵敏,可检测出100fg含量的DNA。重症肌无力患者(n=35)与健康对照(n=15)的IL-2mRNA表达水平无明显差异(P=0.17)。用PHA刺激PBMC,患者和对照的IL-2mRNA表达均明显增多。摘除胸腺或(和)肾上腺皮质激素治疗。
Thereversetranscription(RT),polymerasechainreaction(PCR)andslotblottech-niquewasusedforthequantificationofmessengerribonucleicacid(mRNA).Theexperimentsre-vealedthatthismethodwassensitiveinalowingthedetectionofthetargetcytokinemRNAdowntoatleast100fg.Wedeterminedtheinterleukine-2mRNAexpressionofperipheralbloodmononuclearcels(PBMC)from35patientswithmyastheniagravis(MG)and15healthycontrols.FolowingPHAtreatmentofPBMC,therewereincreasedIL-2mRNAexpressionsinbothgroups.Nodiffer-enceoftheIL-2mRNAlevelswasdetectedinthepatientsandthecontrolseitherwithPHAtreat-mentofPBMCorwithout.ButIL-2mRNAexpressionwasdecreasedinpatientsaftertherapywiththymectomyorglucocorticoidsascomparedtothatbeforethetherapyinthesamepatients.There-sultsshowedthattheRT-PCRandslotblottechniqueswerefoundtobesuitableforthedetectionofcytokineswhichareinthelowerexpressivelevels.Itwasconsideredthatimmunotherapyhadanin-hibitoryefectonIL-2mRNAexpressioninpatientswithMG.
出处
《中华神经科杂志》
CSCD
1996年第5期286-288,共3页
Chinese Journal of Neurology
基金
中国医学科学院科研重点项目基金和卫生部基金
关键词
重症肌无力
IL-2
mRNA
聚合酶链反应
狭缝印迹
MyastheniagravisIL-2mRNAexpressionReversetranscriptionPoly-merasechainreactionSlotblot